Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

July 2013 - FRMC

News

News
Combination Therapy for Patients with Multiple Myeloma
07/22/2013

Tim Casey

Tim Casey
Chicago—An analysis of a phase 3, randomized, multicenter, open-label study found that patients with pretreated relapsed and refractory multiple myeloma had an improvement in health-related quality of life if they received pomalidomide plus...
Chicago—An analysis of a phase 3, randomized, multicenter, open-label study found that patients with pretreated relapsed and refractory multiple myeloma had an improvement in health-related quality of life if they received pomalidomide plus...
Chicago—An analysis of a phase...
07/22/2013
First Report Managed Care
Breakthrough Pain in Cancer Patients
07/22/2013

Tim Casey

Tim Casey
Patients with cancer who had breakthrough pain were statistically significantly more likely to have daily functioning problems compared with cancer patients who are pain-free, according to a database analysis of commercially-insured health...
Patients with cancer who had breakthrough pain were statistically significantly more likely to have daily functioning problems compared with cancer patients who are pain-free, according to a database analysis of commercially-insured health...
Patients with cancer who had...
07/22/2013
First Report Managed Care
BMN 673 for Breast Cancer and Ovarian Cancer
07/22/2013

Tim Casey

Tim Casey
The initial study in humans of the investigational agent BMN 673 found that the oral drug has substantial anti-tumor activity in deleterious germline BRCA ovarian and breast cancer, according to a phase 1/2 trial.
The initial study in humans of the investigational agent BMN 673 found that the oral drug has substantial anti-tumor activity in deleterious germline BRCA ovarian and breast cancer, according to a phase 1/2 trial.
The initial study in humans of...
07/22/2013
First Report Managed Care
Bevacizumab plus Chemotherapy to Treat Cervical Cancer
07/22/2013

Tim Casey

Tim Casey
Patients with recurrent and metastatic cervical cancer who received bevacizumab with their chemotherapy regimens had statistically significant improvement in overall survival compared with those taking chemotherapy alone. 
Patients with recurrent and metastatic cervical cancer who received bevacizumab with their chemotherapy regimens had statistically significant improvement in overall survival compared with those taking chemotherapy alone. 
Patients with recurrent and...
07/22/2013
First Report Managed Care
Ipilimumab plus Sargramostin for Metastatic Melanoma
07/22/2013

Tim Casey

Tim Casey
Chicago—After a year of treatment, 68.9% of patients with metastatic melanoma who took ipilimumab plus sargramostin were alive compared with 52.9% of patients who received ipilimumab alone, according to a multicenter, randomized, phase 2...
Chicago—After a year of treatment, 68.9% of patients with metastatic melanoma who took ipilimumab plus sargramostin were alive compared with 52.9% of patients who received ipilimumab alone, according to a multicenter, randomized, phase 2...
Chicago—After a year of...
07/22/2013
First Report Managed Care
Pazopanib Improves Progression-Free Survival for Advanced Ovarian Cancer
07/22/2013

Tim Casey

Tim Casey
Patients with advanced ovarian cancer who took pazopanib daily after initial treatment with surgery and chemotherapy had significantly longer progression-free survival compared with those who received placebo. 
Patients with advanced ovarian cancer who took pazopanib daily after initial treatment with surgery and chemotherapy had significantly longer progression-free survival compared with those who received placebo. 
Patients with advanced ovarian...
07/22/2013
First Report Managed Care
Enzalutamide for Hormone-Naïve Prostate Cancer
07/22/2013

Tim Casey

Tim Casey
  Chicago—Patients with hormone-naïve prostate cancer who took 160 mg of enzalutamide daily for 24 weeks had a median decrease in prostate-specific antigen (PSA) of 99.6%, according to a phase 2, open-label, single-arm study. In addition,...
  Chicago—Patients with hormone-naïve prostate cancer who took 160 mg of enzalutamide daily for 24 weeks had a median decrease in prostate-specific antigen (PSA) of 99.6%, according to a phase 2, open-label, single-arm study. In addition,...
  Chicago—Patients with...
07/22/2013
First Report Managed Care

Department

Conference Insider
Sorafenib to Treat Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer
07/22/2013

Tim Casey

Tim Casey
Chicago—An international, multicenter, double-blind, randomized, phase 3 trial found that patients with radioactive iodine-refractory differentiated thyroid cancer who took sorafenib had a significant improvement in progression-free survival...
Chicago—An international, multicenter, double-blind, randomized, phase 3 trial found that patients with radioactive iodine-refractory differentiated thyroid cancer who took sorafenib had a significant improvement in progression-free survival...
Chicago—An international,...
07/22/2013
First Report Managed Care
News Connection
Inpatient Care Provider Communication with Outpatient Care Provider
07/22/2013

Tori Socha

Tori Socha
There is a growing model of inpatient care that includes the use of hospitalists, which may be one of the factors exacerbating the already poor level of communication between inpatient and outpatient healthcare providers. The discontinuity of...
There is a growing model of inpatient care that includes the use of hospitalists, which may be one of the factors exacerbating the already poor level of communication between inpatient and outpatient healthcare providers. The discontinuity of...
There is a growing model of...
07/22/2013
First Report Managed Care
News Connection
Predicting Avoidable 30-Day Hospital Readmissions
07/22/2013

Tori Socha

Tori Socha
A common costly component to overall healthcare costs is hospital readmission. The 30-day readmission rate in the United States is 18% according to recent studies, and the cost of readmissions among Medicare beneficiaries is an estimated $17...
A common costly component to overall healthcare costs is hospital readmission. The 30-day readmission rate in the United States is 18% according to recent studies, and the cost of readmissions among Medicare beneficiaries is an estimated $17...
A common costly component to...
07/22/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Report: Cancer Will Kill 13.2 Million a Year by 2030
06/02/2010
06/02/2010
First Report Managed Care
Literature Review: Opioid-Induced Constipation
03/16/2015
These studies focus on the causes, consequences, and management of opioid-induced constipation.
These studies focus on the causes, consequences, and management of opioid-induced constipation.
These studies focus on the...
03/16/2015
First Report Managed Care
News
New Standardized Insurance Forms Could Make Buying Easier
08/23/2011
08/23/2011
First Report Managed Care
News
FDA Approves Denosumab for New Indication
12/10/2014
The FDA approved denosumab for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
The FDA approved denosumab for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
The FDA approved denosumab for...
12/10/2014
First Report Managed Care
News
CMS Announces Voluntary Bundled Payment Model
01/10/2018
The CMS recently announced the launch of a new voluntary bundled payment model that will cover multiple specialties and care services.
The CMS recently announced the launch of a new voluntary bundled payment model that will cover multiple specialties and care services.
The CMS recently announced the...
01/10/2018
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

July 2013 Volume 10 Issue 7

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement